Download App

Log in to access Online Inquiry
Company Overview More
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.
CEO: Love M.D., Ted W.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

GBT Global Blood Therapeutics

26.150+0.690+2.71%
Close 05/27 20:00 ET
26.350+0.2+0.76%
Post Mkt Price 05/27 16:29 ET
High
26.420
Open
25.530
Turnover
40.00M
Low
24.330
Pre Close
25.460
Volume
1.56M
Market Cap
1.70B
P/E(TTM)
Loss
52wk High
41.730
Shares
65.10M
P/E(Static)
Loss
52wk Low
22.670
Float Cap
1.47B
Bid/Ask %
-83.33%
Historical High
87.540
Shs Float
56.28M
Volume Ratio
1.64
Historical Low
12.240
Dividend TTM
--
Div Yield TTM
250
P/B
12.70
Dividend LFY
--
Div Yield LFY
956.02%
Turnover Ratio
2.77%
Amplitude
8.21%
Avg Price
25.647
Lot Size
1
Float Cap
1.47B
Bid/Ask %
-83.33%
Historical High
87.540
Shs Float
56.28M
Volume Ratio
1.64
Historical Low
12.240
Dividend TTM
--
P/B
12.70
Dividend LFY
--
Turnover Ratio
2.77%
Amplitude
8.21%
Avg Price
25.647
Lot Size
1
Price Forecast

No Data

News

Comment